RS50609B - Oralno dezintegrativna farmaceutska kompozicija koja sadrži risperidon - Google Patents

Oralno dezintegrativna farmaceutska kompozicija koja sadrži risperidon

Info

Publication number
RS50609B
RS50609B RSP-2008/0419A RSP20080419A RS50609B RS 50609 B RS50609 B RS 50609B RS P20080419 A RSP20080419 A RS P20080419A RS 50609 B RS50609 B RS 50609B
Authority
RS
Serbia
Prior art keywords
risperidone
orally
desintegrating
pharmaceutical composition
polymethacrylate
Prior art date
Application number
RSP-2008/0419A
Other languages
English (en)
Inventor
Vesna Kroselj
Tadeja Rajer
Marija Rangus
Jozica Gustin
Original Assignee
Krka Tovarna Zdravil D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D.D. filed Critical Krka Tovarna Zdravil D.D.
Publication of RS50609B publication Critical patent/RS50609B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oralno-dezintegrativna farmaceutska kompozicija koja sadrži(a) risperidon ili njegovu so ili rastvor.(b) polimetakrilat,(c) šećerni alkohol, i(d) deizintegrant koji sadrži (i) cross-linked polivinil irolidon i (ii) low-substituted hidroksipropil celulozue. Prijava sadrži 1+15 patentnih zahteva
RSP-2008/0419A 2004-06-15 2005-06-14 Oralno dezintegrativna farmaceutska kompozicija koja sadrži risperidon RS50609B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004028940A DE102004028940A1 (de) 2004-06-15 2004-06-15 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PCT/EP2005/006375 WO2005123084A1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number Publication Date
RS50609B true RS50609B (sr) 2010-06-30

Family

ID=34971693

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0419A RS50609B (sr) 2004-06-15 2005-06-14 Oralno dezintegrativna farmaceutska kompozicija koja sadrži risperidon

Country Status (13)

Country Link
EP (1) EP1768673B1 (sr)
AT (1) ATE402706T1 (sr)
DE (2) DE102004028940A1 (sr)
EA (1) EA010178B1 (sr)
ES (1) ES2311230T3 (sr)
HR (1) HRP20080452T3 (sr)
NO (1) NO20070187L (sr)
PL (1) PL1768673T3 (sr)
PT (1) PT1768673E (sr)
RS (1) RS50609B (sr)
SI (1) SI1768673T1 (sr)
UA (1) UA87692C2 (sr)
WO (1) WO2005123084A1 (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
TW200835527A (en) * 2006-12-26 2008-09-01 Shionogi & Co Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) * 2007-06-15 2008-12-18 Teikokumedix Co., Ltd. リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) * 2008-01-14 2010-12-22 齐鲁制药有限公司 利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224905B1 (en) * 1996-06-17 2001-05-01 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
RU2245136C2 (ru) * 2001-07-27 2005-01-27 Яманоути Фармасьютикал Ко., ЛТД Композиция, включающая тонкодисперсные частицы с замедленным высвобождением для быстроразлагающихся в щечной полости таблеток, и способ ее получения
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
CN1819819B (zh) * 2003-05-07 2011-03-09 株式会社三养社 用于制备速熔片的高度可塑性颗粒
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone

Also Published As

Publication number Publication date
UA87692C2 (ru) 2009-08-10
SI1768673T1 (sl) 2008-12-31
EP1768673A1 (en) 2007-04-04
EA010178B1 (ru) 2008-06-30
PL1768673T3 (pl) 2009-01-30
PT1768673E (pt) 2008-10-21
NO20070187L (no) 2007-03-02
EA200700023A1 (ru) 2007-06-29
HRP20080452T3 (en) 2008-10-31
ES2311230T3 (es) 2009-02-01
DE102004028940A1 (de) 2006-01-12
ATE402706T1 (de) 2008-08-15
WO2005123084A1 (en) 2005-12-29
DE602005008607D1 (de) 2008-09-11
EP1768673B1 (en) 2008-07-30

Similar Documents

Publication Publication Date Title
UA90875C2 (ru) Лекарственные формы пролонгированного действия, которые содержат ранолазин
SG153800A1 (en) Pharmaceutical compositions
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
AP2007003973A0 (en) Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation
IL223545A0 (en) Pharmaceutical compositions
WO2006010423A3 (en) Azaindole inhibitors of mtp and apob
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
GB0408308D0 (en) Pharmaceutical compositions
ZA200702418B (en) Taste-masking Pharmaceutical compositions
HRP20080452T3 (en) Orally disintegrating pharmaceutical composition comprising risperidone
PL1837019T3 (pl) Kompozycja farmaceutyczna rozpadająca się w ustach
GB0406378D0 (en) Novel pharmaceutical compositions
TN2009000447A1 (en) An extented-release composition comprising a somatostatin derivative in microparticles
ZA200604874B (en) Pharmaceutical compositions
WO2006005578A3 (en) Solid pharmaceutical composition comprising mirtazapine
WO2006110185A3 (en) Antiinfective lipopeptides
WO2007071444A3 (en) Esomeprazole arginine
MX2009005804A (es) Composicion farmaceutica de memantina.
IL191992A0 (en) Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
WO2008083191A3 (en) Radiofluorination methods
HK1103027A1 (en) 4-hydroxy tamoxifen gel formulations
EP1747205A4 (en) PHARMACEUTICAL COMPOSITIONS
IL198446A0 (en) Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
GB0422582D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions